Surgically treated ovarian endometriosis association with BRCA1 and BRCA2 mutations

Sarit Aviel‐Ronen, Aviel-Ronen S, Sarit Aviel-Ronen, David Soriano, Soriano D, Elyasaf Shmuel, Shmuel E, Ron Schonman, Schonman R, Rosenblatt K, Kinneret Rosenblatt, Oranit Zadok, Zadok O, Vituri A, Aya Vituri, Daniel S. Seidman, Seidman D, Daniel Seidman, Iris Barshack, Yoram Cohen, Cohen Y
Pathology, research and practice · 2014 · vol. 210(4) , pp. 250–255 · doi:10.1016/j.prp.2013.12.011 · PMID:24472143 · W1979298842
article OA: closed CC0 ⤵ 4 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-09 ⓘ

This study investigated the association between surgically treated ovarian endometriosis and BRCA1/BRCA2 mutations in affected individuals.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Endometriosis is associated with an increased risk of ovarian cancer. Few studies have also shown increased risk of breast cancer. BRCA1/2 mutations are linked to an increased risk of breast and ovarian cancers but their relation to endometriosis is unknown. The objective of this study was to examine the mutation rate of BRCA1/2 among women with surgically treated ovarian endometriosis. We collected 126 specimens from Jewish Ashkenazi women with endometriotic (76) and control non-endometriotic (50) ovarian cysts, reviewed the pathological diagnoses and extracted DNA from all samples. Using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS), samples were examined for the founder germline mutations of BRCA1/2, most common among Ashkenazi Jews. The rate of mutations in each group was calculated and compared. BRCA1/2 mutation rate was 1/76 (1.3%) in the endometriotic cyst study group and 1/50 (2%) in the control non-endometriotic cysts, showing no statistically significant difference between the groups (p=0.84). BRCA1/2 mutation rate was similar to the previously reported rate among Jewish Ashkenazi women. BRCA1/2 mutation rates in patients with endometriotic ovarian cysts and with non-endometriotic ovarian cysts are similar. A larger cohort is required to completely exclude the possibility of an association between BRCA1/2 mutations and surgically treated endometriosis.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Endometriosis Genes, BRCA1 Genes, BRCA2 Ovarian Diseases Adult DNA Mutational Analysis Endometriosis Endometriosis Female Germ-Line Mutation Humans Ovarian Cysts Ovarian Cysts Ovarian Cysts Ovarian Diseases Ovarian Diseases Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (51)

Cited by (4)

Source provenance

europepmc
last seen: 2026-08-29T06:12:09.280863+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:18:40.923139+00:00
unpaywall
last seen: 2026-08-29T06:28:44.313744+00:00
License: CC0 · commercial use OK